Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-04-16 Sale |
2025-04-17 4:08 pm |
Immunovant Inc. | IMVT | Barnett Eva Renee Chief Financial Officer |
2,993 | $14.89 | $44,566 | 396,774 (Direct) |
View |
| 2025-04-16 Sale |
2025-04-17 4:07 pm |
Immunovant Inc. | IMVT | Salzmann Peter Chief Executive Officer |
8,321 | $14.89 | $123,900 | 1,178,191 (Direct) |
View |
| 2025-04-09 Sale |
2025-04-11 4:08 pm |
Immunovant Inc. | IMVT | Stout Jay S Chief Technology Officer |
5,004 | $12.99 | $65,002 | 211,168 (Direct) |
View |
| 2025-04-09 Sale |
2025-04-11 4:07 pm |
Immunovant Inc. | IMVT | Geffner Michael Chief Medical Officer |
6,169 | $12.99 | $80,135 | 227,719 (Direct) |
View |
| 2025-04-09 Sale |
2025-04-11 4:06 pm |
Immunovant Inc. | IMVT | Barnett Eva Renee Chief Financial Officer |
11,063 | $12.99 | $143,708 | 399,767 (Direct) |
View |
| 2025-04-09 Sale |
2025-04-11 4:05 pm |
Immunovant Inc. | IMVT | Salzmann Peter Chief Executive Officer |
28,094 | $12.99 | $364,941 | 1,186,512 (Direct) |
View |
| 2025-03-07 Sale |
2025-03-11 4:18 pm |
Immunovant Inc. | IMVT | Fromkin Andrew J. Director |
8,000 | $19.6 | $156,769 | 91,913 (Direct) |
View |
| 2025-02-19 Sale |
2025-02-21 4:06 pm |
Immunovant Inc. | IMVT | Macias William L. Chief Medical Officer |
2,055 | $20.86 | $42,867 | 357,353 (Direct) |
View |
| 2025-02-19 Sale |
2025-02-21 4:05 pm |
Immunovant Inc. | IMVT | Barnett Eva Renee Chief Financial Officer |
2,814 | $20.86 | $58,700 | 321,952 (Direct) |
View |
| 2025-02-19 Sale |
2025-02-21 4:04 pm |
Immunovant Inc. | IMVT | Salzmann Peter Chief Executive Officer |
15,439 | $20.86 | $322,058 | 948,786 (Direct) |
View |
| 2025-01-22 Sale |
2025-01-24 4:23 pm |
Immunovant Inc. | IMVT | Stout Jay S Chief Technology Officer |
2,195 | $23.59 | $51,780 | 139,991 (Direct) |
View |
| 2025-01-22 Sale |
2025-01-24 4:22 pm |
Immunovant Inc. | IMVT | Geffner Michael Chief Medical Officer |
2,657 | $23.59 | $62,679 | 132,314 (Direct) |
View |
| 2025-01-15 Sale |
2025-01-17 4:07 pm |
Immunovant Inc. | IMVT | Macias William L. Chief Medical Officer |
2,383 | $23.83 | $56,782 | 359,408 (Direct) |
View |
| 2025-01-15 Sale |
2025-01-17 4:05 pm |
Immunovant Inc. | IMVT | Barnett Eva Renee Chief Financial Officer |
2,298 | $23.83 | $54,757 | 324,766 (Direct) |
View |
| 2025-01-15 Sale |
2025-01-17 4:04 pm |
Immunovant Inc. | IMVT | Salzmann Peter Chief Executive Officer |
8,767 | $23.83 | $208,900 | 964,225 (Direct) |
View |
| 2025-01-13 Purchase |
2025-01-15 4:36 pm |
Immunovant Inc. | IMVT | Roivant Sciences Ltd. Director 10% Owner |
16,845,010 | $20 | $336,900,200 | 96,650,341 (Direct) |
View |
| 2025-01-08 Sale |
2025-01-10 4:12 pm |
Immunovant Inc. | IMVT | Barnett Eva Renee Chief Financial Officer |
4,105 | $24.1 | $98,931 | 327,064 (Direct) |
View |
| 2025-01-08 Sale |
2025-01-10 4:11 pm |
Immunovant Inc. | IMVT | Salzmann Peter Chief Executive Officer |
5,105 | $24.1 | $123,031 | 972,992 (Direct) |
View |
| 2024-12-02 Sale |
2024-12-04 4:22 pm |
Immunovant Inc. | IMVT | Pande Atul Director |
7,750 | $28.54 | $221,185 | 106,663 (Indirect Direct) |
View |
| 2024-12-02 Sale |
2024-12-04 4:20 pm |
Immunovant Inc. | IMVT | Hughes Douglas J. Director |
5,425 | $28.54 | $154,830 | 119,585 (Direct) |
View |
| 2024-11-20 Sale |
2024-11-22 4:12 pm |
Immunovant Inc. | IMVT | Levine Mark S. Chief Legal Officer |
3,650 | $25.45 | $92,893 | 319,228 (Direct) |
View |
| 2024-11-20 Sale |
2024-11-22 4:11 pm |
Immunovant Inc. | IMVT | Macias William L. Chief Medical Officer |
3,353 | $25.45 | $85,334 | 361,791 (Direct) |
View |
| 2024-11-20 Sale |
2024-11-22 4:09 pm |
Immunovant Inc. | IMVT | Barnett Eva Renee Chief Financial Officer |
4,174 | $25.45 | $106,228 | 331,169 (Direct) |
View |
| 2024-11-20 Sale |
2024-11-22 4:08 pm |
Immunovant Inc. | IMVT | Salzmann Peter Chief Executive Officer |
16,692 | $25.45 | $424,811 | 978,097 (Direct) |
View |
| 2024-10-23 Sale |
2024-10-25 4:25 pm |
Immunovant Inc. | IMVT | Levine Mark S. Chief Legal Officer |
4,361 | $29.53 | $128,780 | 322,878 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-04-01 Option Award |
2025-04-03 4:55 pm |
N/A 2035-04-01 |
Immunovant Inc. | IMVT | Van Tuyl Christopher Chief Legal Officer |
122,318 | $0 | 232,274 (Direct) |
View |
| 2025-04-01 Option Award |
2025-04-03 4:53 pm |
N/A 2035-04-01 |
Immunovant Inc. | IMVT | Gloria Melanie Chief Operating Officer |
183,478 | $0 | 293,434 (Direct) |
View |
| 2025-04-01 Option Award |
2025-04-03 4:51 pm |
N/A 2035-04-01 |
Immunovant Inc. | IMVT | Stout Jay S Chief Technology Officer |
183,478 | $0 | 323,469 (Direct) |
View |
| 2025-04-01 Option Award |
2025-04-03 4:50 pm |
N/A 2035-04-01 |
Immunovant Inc. | IMVT | Geffner Michael Chief Medical Officer |
244,637 | $0 | 376,951 (Direct) |
View |
| 2025-04-01 Option Award |
2025-04-03 4:48 pm |
N/A 2035-04-01 |
Immunovant Inc. | IMVT | Barnett Eva Renee Chief Financial Officer |
214,058 | $0 | 536,010 (Direct) |
View |
| 2025-04-01 Option Award |
2025-04-03 4:46 pm |
N/A 2035-04-01 |
Immunovant Inc. | IMVT | Salzmann Peter Chief Executive Officer |
640,215 | $0 | 1,589,001 (Direct) |
View |
| 2025-04-01 Option Award |
2025-04-03 4:44 pm |
N/A 2035-04-01 |
Immunovant Inc. | IMVT | Pande Atul Director |
23,788 | $0 | 130,451 (Direct) |
View |
| 2025-04-01 Option Award |
2025-04-03 4:43 pm |
N/A 2035-04-01 |
Immunovant Inc. | IMVT | Hughes Douglas J. Director |
23,788 | $0 | 143,373 (Direct) |
View |
| 2025-04-01 Option Award |
2025-04-03 4:41 pm |
N/A 2035-04-01 |
Immunovant Inc. | IMVT | Fromkin Andrew J. Director |
23,788 | $0 | 115,701 (Direct) |
View |
| 2025-04-01 Option Award |
2025-04-03 4:39 pm |
N/A 2035-04-01 |
Immunovant Inc. | IMVT | MIGAUSKY GEORGE V Director |
23,788 | $0 | 144,851 (Direct) |
View |
| 2025-04-01 Option Award |
2025-04-03 4:37 pm |
N/A 2035-04-01 |
Immunovant Inc. | IMVT | Torti Frank Director |
292,964 | $0 | 928,638 (Direct) |
View |
| 2024-12-16 Option Award |
2024-12-18 5:02 pm |
N/A 2034-12-16 |
Immunovant Inc. | IMVT | Van Tuyl Christopher Chief Legal Officer |
247,402 | $0 | 247,402 (Direct) |
View |
| 2024-11-18 Option Award |
2024-11-20 5:15 pm |
N/A 2034-11-18 |
Immunovant Inc. | IMVT | Gloria Melanie Chief Operating Officer |
247,402 | $0 | 247,402 (Direct) |
View |